Rapid drug abuse test D013

for buprenorphineurinefeces

In response to the growing problem of drug abuse, rapid testing reagents can help medical institutions, analysis laboratories, military, police departments and traffic control divisions to conduct drug screening instantly. The Firstep Drug Screen Test is an immunochromatographic reagent for detection of specified parent drugs or their metabolites in urine specimens. In order to provide customers a wide range of options, Firstep Drug Screen Test can be offered in various formats as single-parameter test or combined to multiple-parameter test. Format Single-parameter Cassette Multiple-parameter Dipcard, including 2 in 1, 5 in 1, 7 in 1 test Multiple-parameter Cassette, including 2 in 1, 3 in 1, 4 in 1, 5 in 1 test Product Features • Short processing time • Customized combinations of drug parameters • High sensitivity, specificity and accuracy Scope of application Suspected drug users Buprenorphine is a synthetic thebaine derivative that has both analgesic and opioid antagonist properties. As an analgesic, it is about 25 to 40 times more potent than morphine. Symptoms of overdosage include confusion, dizziness, pinpoint pupils, hallucinations, hypotension, respiratory difficulty, seizures and coma. Burpenorphine is metabolized in man primarily by N-dealkylation and conjugation to form norbuprenorphine, which is pharmacologically active, and conjugates of buprenorphine and norbuprenorphine. Within 144 hours of a single intramuscular dose of drug, 95% is eliminated, with 68% in the feces and 27% in the urine. Therefore, it can be detected in urine specimens.